Two Sigma Advisers’s EyePoint Pharmaceuticals EYPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $312K | Buy |
33,200
+3,100
| +10% | +$29.2K | ﹤0.01% | 1940 |
|
|
2025
Q1 | $163K | Sell |
30,100
-74,400
| -71% | -$403K | ﹤0.01% | 2175 |
|
|
2024
Q4 | $779K | Sell |
104,500
-62,000
| -37% | -$462K | ﹤0.01% | 1574 |
|
|
2024
Q3 | $1.33M | Sell |
166,500
-9,800
| -6% | -$78.3K | ﹤0.01% | 1274 |
|
|
2024
Q2 | $1.53M | Buy |
176,300
+164,900
| +1,446% | +$1.43M | ﹤0.01% | 1336 |
|
|
2024
Q1 | $236K | Sell |
11,400
-12,500
| -52% | -$258K | ﹤0.01% | 2160 |
|
|
2023
Q4 | $552K | Sell |
23,900
-2,900
| -11% | -$67K | ﹤0.01% | 1881 |
|
|
2023
Q3 | $214K | Buy |
+26,800
| New | +$214K | ﹤0.01% | 2087 |
|
|
2023
Q2 | – | Sell |
-77,700
| Closed | -$228K | – | 2465 |
|
|
2023
Q1 | $228K | Sell |
77,700
-8,100
| -9% | -$23.8K | ﹤0.01% | 2233 |
|
|
2022
Q4 | $300K | Buy |
85,800
+52,100
| +155% | +$182K | ﹤0.01% | 2071 |
|
|
2022
Q3 | $267K | Sell |
33,700
-2,400
| -7% | -$19K | ﹤0.01% | 2096 |
|
|
2022
Q2 | $284K | Sell |
36,100
-4,300
| -11% | -$33.8K | ﹤0.01% | 2140 |
|
|
2022
Q1 | $491K | Sell |
40,400
-20,610
| -34% | -$250K | ﹤0.01% | 1994 |
|
|
2021
Q4 | $747K | Buy |
+61,010
| New | +$747K | ﹤0.01% | 1715 |
|
|
2021
Q2 | – | Sell |
-23,060
| Closed | -$234K | – | 2521 |
|
|
2021
Q1 | $234K | Buy |
+23,060
| New | +$234K | ﹤0.01% | 2308 |
|
|
2015
Q1 | – | Sell |
-1,670
| Closed | -$69K | – | 1962 |
|
|
2014
Q4 | $69K | Sell |
1,670
-710
| -30% | -$29.3K | ﹤0.01% | 2034 |
|
|
2014
Q3 | $105K | Buy |
+2,380
| New | +$105K | ﹤0.01% | 1681 |
|